Free Trial
NASDAQ:PRPH

ProPhase Labs (PRPH) Stock Price, News & Analysis

ProPhase Labs logo
$0.40 +0.02 (+5.68%)
Closing price 04:00 PM Eastern
Extended Trading
$0.40 0.00 (-0.42%)
As of 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About ProPhase Labs Stock (NASDAQ:PRPH)

Key Stats

Today's Range
$0.39
$0.41
50-Day Range
$0.27
$0.39
52-Week Range
$0.22
$4.03
Volume
833,134 shs
Average Volume
3.12 million shs
Market Capitalization
$16.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

ProPhase Labs Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
18th Percentile Overall Score

PRPH MarketRank™: 

ProPhase Labs scored higher than 18% of companies evaluated by MarketBeat, and ranked 873rd out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for ProPhase Labs.

  • Earnings Growth

    Earnings for ProPhase Labs are expected to grow in the coming year, from ($1.27) to ($0.56) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of ProPhase Labs is -0.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of ProPhase Labs is -0.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    ProPhase Labs has a P/B Ratio of 1.61. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about ProPhase Labs' valuation and earnings.
  • Percentage of Shares Shorted

    0.47% of the float of ProPhase Labs has been sold short.
  • Short Interest Ratio / Days to Cover

    ProPhase Labs has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in ProPhase Labs has recently decreased by 51.69%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    ProPhase Labs does not currently pay a dividend.

  • Dividend Growth

    ProPhase Labs does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.47% of the float of ProPhase Labs has been sold short.
  • Short Interest Ratio / Days to Cover

    ProPhase Labs has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in ProPhase Labs has recently decreased by 51.69%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    ProPhase Labs has a news sentiment score of 0.72. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.90 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for ProPhase Labs this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, ProPhase Labs insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 9.60% of the stock of ProPhase Labs is held by insiders.

  • Percentage Held by Institutions

    Only 9.45% of the stock of ProPhase Labs is held by institutions.

  • Read more about ProPhase Labs' insider trading history.
Receive PRPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ProPhase Labs and its competitors with MarketBeat's FREE daily newsletter.

PRPH Stock News Headlines

The Pentagon just made a National Security move...
This "awesome resource" could power America for 30,000 years... We sent one of our smartest researchers.... a consultant who's worked for the likes of J.P. Morgan and Citicorp... into the middle of the Utah desert with a film crew.Why? So he could lead an investigation into a radical new kind of energy that's so abundant, the Dept. of Energy says it could meet America's power needs for the next 2 million years. It's got nothing to do with wind, solar, nuclear, oil or gas.
See More Headlines

PRPH Stock Analysis - Frequently Asked Questions

ProPhase Labs' stock was trading at $0.7571 at the start of the year. Since then, PRPH shares have decreased by 46.7% and is now trading at $0.4037.
View the best growth stocks for 2025 here
.

ProPhase Labs, Inc. (NASDAQ:PRPH) issued its earnings results on Tuesday, May, 20th. The company reported ($0.12) EPS for the quarter, beating the consensus estimate of ($0.18) by $0.06. The firm had revenue of $1.43 million for the quarter, compared to analysts' expectations of $2.45 million.
Read the conference call transcript
.

Shares of PRPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ProPhase Labs investors own include Meta Platforms (META), Pfizer (PFE), Valero Energy (VLO), CymaBay Therapeutics (CBAY), Catalyst Pharmaceuticals (CPRX) and Energy Transfer (ET).

Company Calendar

Last Earnings
5/20/2025
Today
7/02/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PRPH
Employees
130
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$53.36 million
Pretax Margin
-665.83%

Debt

Sales & Book Value

Annual Sales
$6.77 million
Price / Cash Flow
N/A
Book Value
$0.25 per share
Price / Book
1.60

Miscellaneous

Free Float
37,553,000
Market Cap
$16.66 million
Optionable
Optionable
Beta
-0.41

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:PRPH) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners